IVA
Inventiva S.A.NASDAQHealthcare$5.47+0.74%ClosedMarket Cap: $284.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-54.97
P/S
39.92
EV/EBITDA
-2.79
DCF Value
$-9.17
FCF Yield
-21.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.4%
Operating Margin
-621.0%
Net Margin
-1891.7%
ROE
536.4%
ROA
-174.3%
ROIC
-80.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2025 | $4.5M | 61.7% | $-56.8M | $-175.9M | $-1.62 | — |
| Q4 2024 | $6.5M | 108.1% | $-45.3M | $-135.2M | $-2.60 | — |
| FY 2024 | $9.2M | 100.0% | $-97.6M | $-184.2M | $-3.54 | — |
| Q2 2024 | $2.7M | 80.8% | $-52.2M | $-49.0M | $-0.94 | — |
| Q4 2023 | $16.5M | 96.6% | $-47.7M | $-55.2M | $-1.13 | — |
| FY 2023 | $17.5M | 100.1% | $-102.7M | $-110.4M | $-2.43 | — |
| Q2 2023 | $6.6M | 93.1% | $-55.0M | $-55.3M | $-1.31 | — |
| Q4 2022 | $15.4M | 96.9% | $-23.6M | $-24.8M | $-0.59 | — |
| FY 2022 | $12.2M | 140.1% | $-57.1M | $-54.3M | $-1.31 | — |
| Q2 2022 | $67.0K | -677.6% | $-36.5M | $-29.5M | $-0.72 | — |
| Q4 2021 | $4.1M | 86.2% | $-30.7M | $-26.5M | $-0.67 | — |
| FY 2021 | $4.2M | 100.0% | $-52.1M | $-49.6M | $-1.27 | — |